keyword
https://read.qxmd.com/read/38440601/wide-composite-resection-of-sternal-metastasis-reconstruction-using-titanium-mesh-implant-and-myocutaneous-flap-in-differentiated-thyroid-carcinoma-case-report-of-two-cases
#61
JOURNAL ARTICLE
Mit Rojesara, Swati Sattavan, Mohit Sharma, Priyank Rathod, Ketul Puj, Shashank Pandya, Vivek Bande, Ajinkya Pawar, Nilanjan Ghosh, Sankhya Bhat S, Senthil Kumar M
Differentiated Thyroid carcinoma (DTC) with distant skeletal metastases is associated with a very poor prognosis and are unfortunately resistant to radioiodine therapy (RIT). Surgical removal of the metastases in such selected cases is a beneficial adjunct to RIT. We report two cases of DTC with sternal metastases whom we successfully managed with surgical resection of the sternal lesion with reconstruction of the chest wall defect using titanium mesh implant and myocutaneous flap.
February 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38432938/-chemical-design-of-radiohalogenated-agents-using-neopentyl-structure
#62
JOURNAL ARTICLE
Tomoya Uehara
Many useful radionuclides exist among the halogen elements. Fluorine-18 (18 F) is used for positron emission tomography (PET) diagnosis, iodine-123 and iodine-131 (131 I) for single photon emission computed tomography (SPECT) diagnosis, 131 I for nuclear medicine therapy, and iodine-125 (125 I) for research. Astatine-211 (211 At), which can be produced by a cyclotron and is attracting attention as a versatile α-ray emitting radionuclide, also belongs to the halogen family. Therefore, if a labeling agent that can stably hold radio-halogens can be developed, it would be useful for the development of radiotheranostic agents that can be expanded from nuclear medicine diagnosis using PET and SPECT to nuclear medicine therapy using β- -rays and even α-rays...
2024: Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan
https://read.qxmd.com/read/38421515/nuclear-medicine-practice-in-japan-a-report-of-the-ninth-nationwide-survey-in-2022
#63
JOURNAL ARTICLE
Atsutaka Okizaki, Yoshihiro Nishiyama, Yoshitaka Inui, Hideki Otsuka, Kentaro Takanami, Masatoyo Nakajo, Koya Nakatani, Munenobu Nogami, Kenji Hirata, Yukito Maeda, Mana Yoshimura, Hiroshi Wakabayashi
Subcommittee on Survey of Nuclear Medicine Practice in Japan has performed a nationwide survey of nuclear medicine practice every 5 years since 1982 to survey contemporary nuclear medicine practice and its changes over the years. The subcommittee sent questionnaires, including the number and category of examinations as well as the kind of the radiopharmaceuticals during the 30 days of June 2022 to all nuclear medicine institutes in Japan. The total numbers of them for the year 2022 were estimated depends on the 1-month data...
February 29, 2024: Annals of Nuclear Medicine
https://read.qxmd.com/read/38414626/carcinoma-arising-from-thyroglossal-duct-remnants
#64
JOURNAL ARTICLE
Abdulwahid M Salih, Aras J Qaradakhy, Yadgar A Saeed, Aso S Muhialdeen, Hardi M Dhahir, Ari M Abdullah, Shaho F Ahmed, Shko H Hassan, Hawbash M Rahim, Muhammed Bag A Ali, Berun A Abdalla, Bushra O Hussein, Fahmi H Kakamad
Thyroglossal duct cysts (TGDCs) are unusual remnants of the thyroid gland that are rarely observed in association with carcinoma. The present study aimed to showcase the clinical characteristics, diagnosis and management of patients with TGDC carcinoma. It was a single-center study conducted from February 2016 to February 2020. The study involved the retrospective analysis of a series of cases with TGDC carcinoma. A total of 10 patients were included in the study, of whom eight (80%) were females. Their age ranged from 25 to 48 years with a mean age of 39...
April 2024: Biomedical Reports
https://read.qxmd.com/read/38411703/the-influencer-effect-of-dexmedetomidine-on-radioiodine-relevant-to-lacrimal-gland-impairment
#65
JOURNAL ARTICLE
Evin Şingar, Aylin Akbulut, Gökhan Koca, Nuray Yazihan, Hasan İkbal Atilgan, Nihat Yumuşak, Ayten Demir, Ayse Burcu, Meliha Korkmaz
PURPOSE: To assess the potential influencing effects of Dexmedetomidine on impaired lacrimal glands after high-dose radioiodine treatment (RAI). METHODS: Thirty-six rats were arbitrarily separated into 3 groups: Sham, RAI, and Dexmedetomidine. Dexmedetomidine group was given Dexmedetomidine and RAI, the Sham group was given the same millimeters of saline, and the RAI group was given RAI only. All forms of lacrimal glands, including harderian glands (HG), extraorbital (EG), and intraorbital (IG) lacrimal glands, were evaluated for immunohistochemical, histopathologic assessments and also for tissue cytokines, oxidant and antioxidant levels...
February 27, 2024: International Ophthalmology
https://read.qxmd.com/read/38408514/synthesis-and-initial-evaluation-of-radioiodine-labelled-deuterated-tropane-derivatives-targeting-dopamine-transporter
#66
JOURNAL ARTICLE
Jie Liu, Jing Kang, Meihui Qi, Jie Tang, Yi Fang, Chunyi Liu, Jingjing Hong, Jiaojiao Zuo, Zhengping Chen
The dopamine transporter (DAT) is closely related to a variety of neurological disorders including Parkinson's disease (PD) and other neurodegenerative diseases. In vivo imaging of DAT with radio-labelled tracers has become a powerful technique in related disorders. The radioiodine-labelled tropane derivative [123 I]FP-CIT ([123 I]1a) is widely used in clinical single photon emission computed tomography (SPECT) imaging as a DAT imaging agent. To develop more metabolically stable DAT radioligands for accurate imaging, this work compared two novel deuterated tropane derivatives ([131 I]1c-d) with non-deuterated tropane derivatives ([131 I]1a-b)...
February 24, 2024: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/38400843/poorly-differentiated-thyroid-carcinomas-conceptual-controversy-and-clinical-impact
#67
REVIEW
Andrés Coca-Pelaz, Juan P Rodrigo, Abbas Agaimy, Michelle D Williams, Nabil F Saba, Sandra Nuyts, Gregory W Randolph, Fernando López, Vincent Vander Poorten, Luiz P Kowalski, Francisco J Civantos, Mark E Zafereo, Antti A Mäkitie, Oded Cohen, Iain J Nixon, Alessandra Rinaldo, Alfio Ferlito
Poorly differentiated thyroid carcinomas (PDTC) are rare diseases; nevertheless, they account for the majority of deaths from non-anaplastic follicular cell-derived thyroid carcinomas. Establishing the diagnosis and treatment of PDTC is challenging given the low incidence and the lack of standardization of diagnostic criteria. These limitations hamper the ability to compare therapeutic modalities and outcomes between recent and older studies. Recently, the 5th edition of the classification of endocrine tumors has been published, which includes changes in nomenclature and the addition of the disease entity of "differentiated high-grade follicular cell-derived carcinomas"...
February 24, 2024: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/38397952/minimal-extrathyroid-extension-mete-as-the-only-risk-factor-in-patients-with-papillary-thyroid-carcinoma-pc-its-clinical-impact-on-recurrence-and-outcome-during-long-term-follow-up
#68
JOURNAL ARTICLE
Andrea Marongiu, Susanna Nuvoli, Andrea De Vito, Sonia Vargiu, Angela Spanu, Giuseppe Madeddu
Minimal extrathyroid extension (mETE) effect on papillary thyroid carcinoma (PC) prognosis is still debated even more so now that this factor has been removed in the 8th AJCC Edition, supporting the hypothesis that mETE is not associated with aggressive tumors. We retrospectively enrolled 91 PC patients (Group 1) submitted to total thyroidectomy and radioiodine ablation. At the time of the primary tumor surgery, mETE was ascertained in all patients with no other risk factors, such as multifocality, vascular invasion, neck and distant metastases, and aggressive histological variants...
February 2, 2024: Biomedicines
https://read.qxmd.com/read/38390734/evaluation-of-the-relationship-between-mobile-phone-usage-and-mirna-574-5p-and-mirna-30c-5p-levels-in-thyroid-cancer-patients
#69
JOURNAL ARTICLE
Zekiye Hasbek, Ayça Taş, Seyit Ahmet Ertürk, Barış Sarıakçalı, Özge Ulaş Babacan, Gülhan Duman, Yavuz Siliğ
OBJECTIVES: This study aimed to evaluate the relationship between mobile phone usage and miRNA-574-5p and miRNA-30C-5p levels in patients diagnosed with differentiated thyroid cancer (DTC). METHODS: Fifty patients diagnosed with DTC and 50 healthy volunteers were included in the study. miRNA-574-5p and miRNA-30C-5p gene expression levels in the blood of all subjects were analyzed by real time-polymerase chain reaction, and a questionnaire including various questions was administered to both groups...
February 22, 2024: Molecular Imaging and Radionuclide Therapy
https://read.qxmd.com/read/38389219/unusual-131i-uptake-caused-by-paronychia-in-a-patient-with-papillary-thyroid-cancer
#70
JOURNAL ARTICLE
Jun Yang, Zhengzhou Pan, Xinhui Su
A 33-year-old woman was referred for radioiodine 6 months after total thyroidectomy and neck dissection for papillary thyroid cancer. Posttherapy whole-body 131I scintigraphy showed not only the known activity in the neck but also accumulated activity in both feet. SPECT/CT revealed focal uptake in bilateral great toenails. On further clinical evaluation and follow-up, the patient was diagnosed as paronychia of the great toenails.
February 23, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38388076/second-radioiodine-treatment-in-patients-with-differentiated-thyroid-carcinoma-causes-and-effects
#71
JOURNAL ARTICLE
María de Las Nieves Sicilia Pozo, Francisco José Pena Pardo, Mariano Amo Salas, Marcos Cruz Montijano, Javier Torres Hernández, Amanda Padilla Bermejo, Cristina Montalbán Méndez, María Zhao Montero, Ángel Soriano Castrejón, Ana María García Vicente
INTRODUCTION: Patients with incomplete response to initial therapy of thyroid cancer can be managed with ongoing observation or potentially additional therapies. Our aim was to assess the effect of a second radioactive iodine treatment (RAIT) and its relationship with causes and clinical variables. MATERIAL AND METHODS: Patients undergoing a second RAIT for biochemical or structural incomplete response to initial therapy of DTC were retrospectively included (n=120)...
January 2024: Endocrinología, diabetes y nutrición
https://read.qxmd.com/read/38382201/evaluation-of-a-novel-sensitive-thyroid-stimulating-hormone-assay-as-a-diagnostic-test-for-thyroid-disease-in-cats
#72
JOURNAL ARTICLE
Mark E Peterson, Eric Dougherty, Mark Rishniw
OBJECTIVE: Clinicians commonly use thyroid-stimulating hormone (TSH) concentrations to diagnose thyroid disorders in humans and dogs. In cats, canine TSH chemiluminescent immunoassays (CLIA) assays are commonly used to measure TSH, but these TSH-CLIAs cannot measure low TSH concentrations (< 0.03 ng/mL) and therefore cannot distinguish between low-normal concentrations and truly low TSH concentrations (characteristic of hyperthyroidism). Our aim was to evaluate a novel TSH assay based on bulk acoustic wave (BAW) technology that has lower functional sensitivity (0...
May 1, 2024: American Journal of Veterinary Research
https://read.qxmd.com/read/38379836/experimental-and-numerical-study-of-radioiodine-sorption-and-transport-in-hanford-sediments
#73
JOURNAL ARTICLE
Xiaoliang He, Mark L Rockhold, Yilin Fang, Amanda R Lawter, Vicky L Freedman, Rob D Mackley, Nikolla P Qafoku
Radioiodine (129 I) poses a potential risk to human health and the environment at several U.S. Department of Energy sites, including the Hanford Site, located in southeastern Washington State. Experimental studies and numerical modeling were performed to provide a technical basis for field-scale modeling of iodine sorption and transport behavior. The experiments were carried out using six columns of repacked contaminated sediments from the Hanford Site. Although iodate has been determined to be the dominant iodine species at the Hanford Site, the sorption and transport behaviors of different iodine species were investigated in a series of column experiments by first leaching sediments with artificial groundwater (AGW) followed by AGW containing iodate (IO3 - ), iodide (I- ), or organo-iodine (2-iodo-5-methoxyphenol, C7 H7 IO2 )...
February 15, 2024: ACS Earth & Space Chemistry
https://read.qxmd.com/read/38376620/nose-to-brain-delivery-of-mirtazapine-via-lipid-nanocapsules-preparation-statistical-optimization-radiolabeling-in-vivo-biodistribution-and-pharmacokinetic-study
#74
JOURNAL ARTICLE
Mennatullah M Ibrahim, Emad B Basalious, Mohamed A El-Nabarawi, Amal Ia Makhlouf, Marwa Eid Sayyed, Ismail Taha Ibrahim
Mirtazapine (MZPc) is an antidepressant drug which is approved by the FDA. It has low bioavailability, which is only 50%, in spite of its rapid absorption when orally administered owing to high first-pass metabolism. This study was oriented towards delivering intranasal (IN) mirtazapine by a direct route to the brain by means of preparing lipid nanocapsules (LNCs) as a targeted drug delivery system. MZP-LNCs were constructed by solvent-free phase inversion temperature technique applying D-Optimal mixture design to study the impact of 3 formulation variables on the characterization of the formulated nanocapsules...
February 20, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38374853/the-thyroid-swing-a-patient-s-journey-from-hypothyroidism-to-hyperthyroidism
#75
Haifa Alnahdi
The flip from hyperthyroidism (HT), as observed in Graves' disease (GD) cases, to hypothyroidism associated with Hashimoto's disease (HD) has been widely recognized and documented. However, the converse is infrequently observed. The observed phenomenon is likely attributed to the major role played by thyroid-stimulating hormone receptor antibodies (TRAbs) in this alternating disease pattern and a substantial reduction in thyroid tissue mass that could be stimulated by these antibodies. Therefore, here we present a case of one middle-aged individual experiencing this transitional switch from hypothyroidism to GD...
January 2024: Curēus
https://read.qxmd.com/read/38374795/acute-kidney-injury-after-thyroid-hormone-withdrawal-in-an-adolescent-with-papillary-thyroid-carcinoma
#76
JOURNAL ARTICLE
Yavuz Özer, Rüveyda Gülmez, Hande Turan, Gürkan Tarçın, Dilek Bingöl Aydın, Olcay Evliyaoğlu, Oya Ercan
OBJECTIVES: We report a patient with papillary thyroid carcinoma (PTC) who developed acute kidney injury (AKI) and elevated creatine kinase (CK) after thyroid hormone withdrawal (THW) prior to radioiodine therapy. CASE PRESENTATION: A 12-year-old female patient who had undergone total thyroidectomy for PTC one year ago presented with leg pain for the past 2 days. Following THW 3 weeks ago, the case had received 70 mCI radioiodine treatment 6 days ago. Serum creatinine (1...
February 20, 2024: Journal of Clinical Research in Pediatric Endocrinology
https://read.qxmd.com/read/38359759/investigation-of-bismuth-based-metal-organic-frameworks-for-effective-capture-and-immobilization-of-radioiodine-gas
#77
JOURNAL ARTICLE
Young Eun Jung, Jae Hwan Yang, Man-Sung Yim
In this study, we investigated the use of Bi-mna, a specific type of bismuth metal organic framework (MOF) for the capture and disposal of iodine, a key nuclide of concern in nuclear fuel reprocessing plants and nuclear power plants. To find the suitable form of Bi-mna for the purpose, experiments were performed by synthesizing four different Bi-mna with varying reagent ratios and connecting iodine adsorption and conversion for immobilization. After iodine adsorption and characterization to investigate their adsorption mechanisms, the Bi-mna samples went through conversion for immobilization to fix captured iodine into the adsorbents...
February 12, 2024: Journal of Hazardous Materials
https://read.qxmd.com/read/38351437/tyrosine-kinase-inhibitors-for-radioiodine-refractory-differentiated-thyroid-cancer-a-systematic-review-and-meta-analysis
#78
REVIEW
Jiayi Yu, Zheran Liu, Yonglin Su, Xingchen Peng, Yuping Xie
BACKGROUND: The poor overall prognosis of radioiodine refractory thyroid cancer is an inevitable challenge in managing this disease. A series of trials have demonstrated the antitumor activity of tyrosine kinase inhibitors (TKIs) in radioiodine refractory differentiated thyroid cancer (RAIR-DTC). However, the available evidence cannot determine the optimal choice of TKI in RAIR-DTC. METHODS: This study searched PubMed, EMBASE, Cochrane databases, and the ClinicalTrials website...
February 13, 2024: Clinical Endocrinology
https://read.qxmd.com/read/38346701/-systemic-therapies-for-advanced-thyroid-cancer-an-update
#79
JOURNAL ARTICLE
Tim Brandenburg, Yara Maria Machlah, Dagmar Führer-Sakel
Based on phase III clinical studies, four multi-kinase inhibitors (MKI) are approved for the treatment of progressive radioiodine-refractory differentiated thyroid carcinoma (rrDTC) and medullary thyroid carcinoma (MTC) in Germany. Only recently, based on the randomized trial COSMIC-311, Cabozantinib has been approved as a second-line treatment option in advanced rrDTC. As first in-label selective RET-Inhibitor, Selpercatinib showed promising efficacy in advanced MTC (first line) with RET mutations and rrDTC (second line) with RET fusions along with fewer side effects...
February 12, 2024: Laryngo- Rhino- Otologie
https://read.qxmd.com/read/38341406/ultralight-crystalline-hybrid-composite-material-for-highly-efficient-sequestration-of-radioiodine
#80
JOURNAL ARTICLE
Sahel Fajal, Writakshi Mandal, Arun Torris, Dipanjan Majumder, Sumanta Let, Arunabha Sen, Fayis Kanheerampockil, Mandar M Shirolkar, Sujit K Ghosh
Considering the importance of sustainable nuclear energy, effective management of radioactive nuclear waste, such as sequestration of radioiodine has inflicted a significant research attention in recent years. Despite the fact that materials have been reported for the adsorption of iodine, development of effective adsorbent with significantly improved segregation properties for widespread practical applications still remain exceedingly difficult due to lack of proper design strategies. Herein, utilizing unique hybridization synthetic strategy, a composite crystalline aerogel material has been fabricated by covalent stepping of an amino-functionalized stable cationic discrete metal-organic polyhedra with dual-pore containing imine-functionalized covalent organic framework...
February 10, 2024: Nature Communications
keyword
keyword
100757
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.